What Is Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency? AADC deficiency is an ultra-rare genetic disorder. It affects how your cells send signals to each other. People born with this condition ...
Acid resistance is a crucial property that enterobacteria must possess to withstand host acidic environments during infection ...
Dopa decarboxylase, an enzyme involved in the synthesis of the neurotransmitter dopamine, catalyses the formation of functional dopamine through decarboxylation of a precursor tyrosine derivative. In ...
Aromatic amino acid decarboxylase (AADC) deficiency is a rare, autosomal recessively inherited neurometabolic disorder characterised by markedly reduced synthesis of key monoamine neurotransmitters ...
Dopa-Decarboxylase-Hemmstoffe, E dopa decarboxylase inhibitors, bei der Behandlung der Parkinson-Krankheit in Kombination mit Levodopa (Dopa) verwendete Substanzen, welche die enzymatische ...
Kebillidi is the first gene therapy to gain FDA approval for the treatment of aromatic L-amino acid decarboxylase deficiency. The FDA has approved PTC Therapeutics’ Kebillidi (eladocagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results